APRE vs GOOGL · $10.4M cap vs P/E 26, rev $402.84B
Aprea Therapeutics Inc (APRE) versus Alphabet Inc Class A (GOOGL) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Alphabet Inc Class A (GOOGL) is a internet content & information company listed on US. It is led by Sundar Pichai.
APRE does not have a complete income-statement cache yet.
Latest reported GOOGL revenue for 2025-12-31 was $402.84B. Net income was $132.17B. Revenue was up 15.1% from 2024-12-31 to 2025-12-31. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
APRE currently screens at market cap $10.4M. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
Not investment advice. Open the APRE and GOOGL stock pages for the full models.
Not investment advice.